Post Sourcing Request Exhibition
Xi'an Manareco New Materials Co.,Ltd
Five years of qualification Audited Supplier

In This Store

  • In This Store
  • On Pharma Sources.com
Favorites
You are here:   Home > Suppliers > Xi'an Manareco New Materials Co.,Ltd

Xi'an Manareco New Materials Co.,Ltd

Recommended Products
(S)-N-Boc-2-aminomethylmorpholine

(S)-N-Boc-2-aminomethylmorpholine
(S)-5-[(biphenyl-4-yl)Methyl]pyrrolidin-2-one

(S)-5-[(biphenyl-4-yl)Methyl]pyrrolidin-2-one
(S)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran

(S)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran
2,6-dimethylhepta-2,5-dien-4-one

2,6-dimethylhepta-2,5-dien-4-one
2-(5-bromo-2-fluorobenzyl)benzo[b]thiophene

2-(5-bromo-2-fluorobenzyl)benzo[b]thiophene
2-((2S,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-2H-1,2,4-triazo

2-((2S,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-2H-1,2,4-triazo
2-[2-(3-Methoxyphenyl)ethyl]phenol

2-[2-(3-Methoxyphenyl)ethyl]phenol
(1R,2S)-1-(3,5-bis(trifluoroMethyl)phenyl)-2-aMinopropan-1-ol

(1R,2S)-1-(3,5-bis(trifluoroMethyl)phenyl)-2-aMinopropan-1-ol
Potassium di-tert-butylphosphate

Potassium di-tert-butylphosphate
1-Bromo-4-chloro-5-(4-ethoxybenzyl)-2-methoxybenzene

1-Bromo-4-chloro-5-(4-ethoxybenzyl)-2-methoxybenzene
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, sodium salt

1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, sodium salt
Methyl 5-tert-butyl-2-hydroxybenzoate

Methyl 5-tert-butyl-2-hydroxybenzoate
1-​Propanone, 2-​fluoro-​1-​[(3aS,​6aS)​-​hexahydropyrrolo[3,​4-​b]​pyrrol-​5(1H)​-​yl]​-​2-​methyl-

1-​Propanone, 2-​fluoro-​1-​[(3aS,​6aS)​-​hexahydropyrrolo[3,​4-​b]​pyrrol-​5(1H)​-​yl]​-​2-​methyl-
Methyl 1-(methylamino)cyclopentanecarboxylate 4-methylbenzenesulfonic acid

Methyl 1-(methylamino)cyclopentanecarboxylate 4-methylbenzenesulfonic acid
6-Hydroxy-2-naphthimidamide methanesulfonate

6-Hydroxy-2-naphthimidamide methanesulfonate
(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one

(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one
4-Pyridinealdoxime

4-Pyridinealdoxime
4-Phenylbutyric acid

4-Phenylbutyric acid
4-Fluoro-5-isopropyl-2-methoxyphenylboronic acid

4-Fluoro-5-isopropyl-2-methoxyphenylboronic acid
4-Chloro-6-iodo-7H-pyrrolo[2,3-d]pyrimidine

4-Chloro-6-iodo-7H-pyrrolo[2,3-d]pyrimidine
4,5,6,7-tetrahydro-5-methyl-Thiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride

4,5,6,7-tetrahydro-5-methyl-Thiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride
(3R)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-[[(1R)-1-phenylethy

(3R)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-[[(1R)-1-phenylethy
1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone

1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone
(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one

(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one
2-Bromothiophene-3-carboxylic acid

2-Bromothiophene-3-carboxylic acid
tert-butyl 4-aminobutanoate,hydrochloride

tert-butyl 4-aminobutanoate,hydrochloride
1-(Perfluorohexyl)octane

1-(Perfluorohexyl)octane
2-(5-Bromo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene

2-(5-Bromo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene
1-Hydroxy-2-naphthoic acid

1-Hydroxy-2-naphthoic acid
Gadobutrol

Gadobutrol
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione

(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione
Bis(cyclopentadienyl)zirconium dichloride

Bis(cyclopentadienyl)zirconium dichloride
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol

(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol
4-Guanidinobenzoic acid hydrochloride

4-Guanidinobenzoic acid hydrochloride
4-Amino-5-chloro-2-methoxybenzoic acid

4-Amino-5-chloro-2-methoxybenzoic acid
(3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride

(3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride
(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valine

(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valine
2-Ethoxyethyl 4-methylbenzenesulfonate

2-Ethoxyethyl 4-methylbenzenesulfonate
2,3,4-Trifluorobenzoic acid

2,3,4-Trifluorobenzoic acid
2-Acetylamidomethyl-4-(4-fluorobenzyl)morpholine

2-Acetylamidomethyl-4-(4-fluorobenzyl)morpholine
Diethyl(3-pyridyl)borane

Diethyl(3-pyridyl)borane
8-Amino-2(1H-tetrazole-5-yl)-chromen-4-one hydrochloride

8-Amino-2(1H-tetrazole-5-yl)-chromen-4-one hydrochloride
5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde

5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde
5-Amino-4-imidazolecarboxamide

5-Amino-4-imidazolecarboxamide
4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene

4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene
(R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane

(R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane
Sitagliptin phosphate monohydrate

Sitagliptin phosphate monohydrate
(Z)-4-(4-((piperidin-1-yl)methyl)pyridin-2-yloxy)but-2-en-1-ol

(Z)-4-(4-((piperidin-1-yl)methyl)pyridin-2-yloxy)but-2-en-1-ol
Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate

Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate
Fomesafen

Fomesafen
Diethyl aminomalonate hydrochloride

Diethyl aminomalonate hydrochloride
P-[[(1S)-2-[4-(Benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid

P-[[(1S)-2-[4-(Benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
4-​Hydroxy-​7-​phenoxy-​3-​Isoquinolinecarboxyl​ic acid ethyl ester

4-​Hydroxy-​7-​phenoxy-​3-​Isoquinolinecarboxyl​ic acid ethyl ester
N-[4-(4-Fluorophenyl)-6-isopropyl-5-[(1E)-3-oxo-1-propenyl]-2-pyriMidinyl]-N-Methyl-MethanesulfonaMi

N-[4-(4-Fluorophenyl)-6-isopropyl-5-[(1E)-3-oxo-1-propenyl]-2-pyriMidinyl]-N-Methyl-MethanesulfonaMi
4-[1-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-1-methylethyl]-benzeneethanol

4-[1-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-1-methylethyl]-benzeneethanol
2-[[(3aR,4S,6R,6aS)-6-[[5-Amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-

2-[[(3aR,4S,6R,6aS)-6-[[5-Amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-
2-Ethylpyridine

2-Ethylpyridine
(R)-(-)-2-AMino-1-propanol

(R)-(-)-2-AMino-1-propanol
Tert-butyl (1R,2S,5S)-2-(2-(5-chloropyridin-2-ylamino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohex

Tert-butyl (1R,2S,5S)-2-(2-(5-chloropyridin-2-ylamino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohex
Ethyl 7-fluoro-1,6-dimethyl-4-oxo-1,4-dihydro-[1,3]thiazetidino[3,2-a]quinoline-3-carboxylate hydrof

Ethyl 7-fluoro-1,6-dimethyl-4-oxo-1,4-dihydro-[1,3]thiazetidino[3,2-a]quinoline-3-carboxylate hydrof
Sulfathiazole

Sulfathiazole
Tert-butyl 4-(1H-benzo[d]iMidazol-2-yl)piperidine-1-carboxylate

Tert-butyl 4-(1H-benzo[d]iMidazol-2-yl)piperidine-1-carboxylate
[4-[4-(4-Hydroxyphenyl)-1-piperazinyl]phenyl]carbamic acid phenyl ester

[4-[4-(4-Hydroxyphenyl)-1-piperazinyl]phenyl]carbamic acid phenyl ester
2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxaldehyde oxalate

2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxaldehyde oxalate
1,6-dimethyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazetidino[3,2-a]quinoline-3-carboxylic aci

1,6-dimethyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-[1,3]thiazetidino[3,2-a]quinoline-3-carboxylic aci
((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)-tetrahydrofuran-3-yl)methyl 4-meth

((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)-tetrahydrofuran-3-yl)methyl 4-meth
[4'-(pentyloxy)[1,1'-biphenyl]-4-yl]boronic acid

[4'-(pentyloxy)[1,1'-biphenyl]-4-yl]boronic acid
N-[2-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-6-methoxyphenyl]methanesulfonamide

N-[2-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-6-methoxyphenyl]methanesulfonamide
4-Piperidineethanol hydrochloride

4-Piperidineethanol hydrochloride
7-Methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene

7-Methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene
4-Tert-butyl-2-methoxybenzyl bromide

4-Tert-butyl-2-methoxybenzyl bromide
2-Chloro-5-iodobenzoic acid

2-Chloro-5-iodobenzoic acid
2-(4-fluoro-5-isopropyl-2-methoxyphenyl)-5,5-dimethylcyclohex-1-enecarbaldehyde

2-(4-fluoro-5-isopropyl-2-methoxyphenyl)-5,5-dimethylcyclohex-1-enecarbaldehyde
1-benzyl-3-(benzyloxy)piperidin-4-one hydrochloride

1-benzyl-3-(benzyloxy)piperidin-4-one hydrochloride
(S)-1-Benzyl-3-pyrrolidinol

(S)-1-Benzyl-3-pyrrolidinol
2,2-diallylpent-4-en-1-amine

2,2-diallylpent-4-en-1-amine
3(2H)-Furanone, 4-bromo-2,2-dimethyl-5-[4-(methylsulfonyl)phenyl]-

3(2H)-Furanone, 4-bromo-2,2-dimethyl-5-[4-(methylsulfonyl)phenyl]-
(1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato (phenyl)methyl)holmium

(1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato (phenyl)methyl)holmium
Categories
Contact Supplier
  • From:
  • To:
    Xi'an Manareco New Materials Co.,Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)
  • Verification:
Previous page 1 2 3 4 5 6 7 Next page
Company Profile
Xi'an Manareco New Materials Co.,Ltd

Xi'an Manareco New Materials Co., Ltd. was established in 1999, whose shares are jointly held by Beijing Manareco Holding Corp. Ltd, CapitalEdge Investment Management Co., Ltd., Eastern Ocean (Wuhu) Equity Investment Fund (LLP),Shanghai Pivot Capital Co., Ltd. and other well-known investment institutions as well as internal middle and senior managers. It is a high-tech company which focuses on R&D, manufacture and marketing of organic new materials, involving in liquid crystal singles, OLED materials and pharmaceutical intermediates, which will be applied to LC mixtures, OLED final materials, and APIs. Also, the final application areas of our products include TFT-LCD, OLED and pharmaceutical preparation.

There are nearly 1,400 full-time employees in Xi’an Manareco, and 50% of which have bachelor's degree. The company consists of administrative and R&D base in Xi’an headquarters and two production bases in Weinan and Pucheng, which can provide one-stop service from lab work, pilot to mass production. It has more than 30 patents and 30 production lines. Over 2,000 display material chemicals have been developed, and self-developed synthetic route has exceeded 3,500.

As a representative enterprise in the field of liquid crystal display materials, Xi'an Manareco has established strategic partnerships with major liquid crystal manufacturers around the world and occupied the high-end market of liquid crystal singles for a long time. Also, as one of the leading companies in OLED material, the company stands in the leading position of domestic OLED material development, and it has set up cooperation relationship with international leading companies who occupy almost 70% market share for global OLED final materials, standing the important position in their supply chains. Furthermore, in pharmaceutical area, owing to the outstanding R&D capability, Xi’an Manareco has became an important supplier for international drug giants. 

Facing the great strategic opportunity of LCD material market transferring from abroad to home and OLED material industry rising rapidly, the company has deepened delicacy management, improved management level and risk prevention ability, and reinforced endogenous driving force for sustainable development. With the management idea of "Openness, Integration, Innovation, Development", the company will actively explore new products, new customers and new fields. By virtue of strong R&D and innovation capabilities and industrialization advantage, Xi'an Manareco is committed to becoming an excellent enterprise in the high-end fine chemicals industry.

more >
Our Company Our Business

Year of Establishment: 2001

Total Assets(USD): More than 99,999,999

Total Number of Staff: more than 1000

Main Competitive Advantages: Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages:

Patents and Copyrights:

Send Inquiry View More
Send your message to this supplier
  • From:
  • To:
    Xi'an Manareco New Materials Co.,Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service